Home / EGFL7 Knockout Cell Lines

EGFL7 Knockout Cell Lines

Gene: EGFL7

Official Full Name: EGF like domain multiple 7provided by HGNC

Gene Summary: This gene encodes a secreted endothelial cell protein that contains two epidermal growth factor-like domains. The encoded protein may play a role in regulating vasculogenesis. This protein may be involved in the growth and proliferation of tumor cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO22922 EGFL7 Knockout cell line (HeLa) Human EGFL7 1:3~1:6 Negative Online Inquiry
KO22923 EGFL7 Knockout cell line (HCT 116) Human EGFL7 1:2~1:4 Negative Online Inquiry
KO22924 EGFL7 Knockout cell line (HEK293) Human EGFL7 1:3~1:6 Negative Online Inquiry
KO22925 EGFL7 Knockout cell line (A549) Human EGFL7 1:3~1:4 Negative Online Inquiry

Background

EGFL7 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the expression of the EGFL7 gene, known for its role in vascular development and cell adhesion. These cell lines are crucial tools for researchers seeking to investigate the biological functions and molecular pathways associated with the EGFL7 gene, particularly in developmental biology, cancer research, and tissue regeneration.

The primary function of these cell lines is to facilitate the study of gene function by allowing researchers to observe the phenotypic changes that occur when the EGFL7 gene is silenced. Mechanistically, the absence of EGFL7 affects processes such as angiogenesis and extracellular matrix interactions, providing insights into not only normal physiological functions but also the pathological states associated with diseases like cancer and cardiovascular disorders.

In scientific research, EGFL7 knockout models are invaluable for elucidating the gene's role in various biological processes. Clinically, these models can be employed to investigate potential therapeutic avenues, including targeted treatments that could modulate vascular pathology or enhance tissue repair mechanisms.

One of the significant advantages of our EGFL7 Gene Knockout Cell Lines is their reliability and reproducibility, which are enhanced by the use of CRISPR-Cas9 technology for precise gene editing. Unlike traditional models that may yield variable results due to off-target effects or incomplete knockout efficiency, these cell lines ensure consistent experimental outcomes, thereby reducing time and resources spent on validation.

For researchers and clinicians focusing on molecular and cellular biology, these knockout cell lines represent a valuable asset, empowering them to open new avenues of exploration and discovery. Their precise mechanism of action and adaptability for High-Throughput Screening assays further enhance their utility in both academic and industrial laboratories.

At [Your Company Name], we pride ourselves on our commitment to advancing scientific research through high-quality, well-characterized biological products. Our expertise in genetic engineering ensures that our EGFL7 Gene Knockout Cell Lines meet the rigorous demands of contemporary biomedical research, enabling scientists to push the boundaries of knowledge in their fields.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.